1185 related articles for article (PubMed ID: 29016684)
1. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
2. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
3. Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea.
Chang J; Sung H; Jo KW; Shim TS; Kim MN
Jpn J Infect Dis; 2021 Nov; 74(6):537-542. PubMed ID: 33790071
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
5. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
7. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
10. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
Ozkutuk N; Surucüoglu S
Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
15. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
16. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
[TBL] [Abstract][Full Text] [Related]
17. Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
Mekkaoui L; Hallin M; Mouchet F; Payen MC; Maillart E; Clevenbergh P; Georgala A; Van den Wijngaert S
PLoS One; 2021; 16(4):e0249734. PubMed ID: 33831077
[TBL] [Abstract][Full Text] [Related]
18. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility.
Geleta DA; Megerssa YC; Gudeta AN; Akalu GT; Debele MT; Tulu KD
BMC Microbiol; 2015 Oct; 15():220. PubMed ID: 26483194
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
[TBL] [Abstract][Full Text] [Related]
20. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
